A collaborative study was conducted on AOAC First Action Method 2011.20: 5′-Mononucleotides in Infant Formula and Adult/Pediatric Nutritional Formula. After the successful analysis of National Institute of Standards and Technology (NIST) 1849a Standard Reference Material (SRM) as a practice sample, 12 laboratories participated in the analysis of duplicate samples of six different infant formula products. The samples were dissolved in high-salt solution to inhibit protein and fat interactions, with the nucleotides [uridine 5′-monophosphate (UMP), inosine 5′-monophosphate (IMP), adenosine 5′-monophosphate (AMP), guanosine 5′-monophosphate (GMP), and cytidine 5′-monophosphate (CMP)] separated from the sample matrix by strong-anion exchange SPE, followed by chromatographic analysis using a C 18 stationary phase with gradient elution, UV detection, and quantitation by an internal standard technique using thymidine 5′-monophosphate.
A. Principle
The sample is dissolved in high-salt solution to inhibit protein and fat interactions. The 5′-mononucleotides-uridine 5′-monophosphate (UMP), inosine 5′-monophosphate (IMP), adenosine 5′-monophosphate (AMP), guanosine 5′-monophosphate (GMP), and cytidine 5′-monophosphate (CMP)-are separated from the sample matrix by strong-anion exchange SPE, followed by chromatographic analysis using a C 18 stationary phase with gradient elution, UV detection, and quantitation by an internal standard (IS) technique using thymidine 5′-monophosphate (TMP). (k) Chromabond SB polypropylene strong-anion exchange SPE cartridges.-6 mL × 1000 mg (Macherey-Nagel, Düren, Germany) or equivalent.
B. Apparatus
(l) Filter membranes.-0.45 μm nylon. 
C. Reagents

D. Reagent Preparation
E. Standard Preparation
See Table 2011 .20A for the UV absorbance maxima and extinction coefficients for nucleotide 5′-monophosphates. (1) Calibration standard 1.-Pipette 0.25 mL working standard and 1 mL internal standard into a 25 mL volumetric flask and make to volume with water.
(2) Calibration standard 2.-Pipette 0.5 mL working standard and 1 mL internal standard into a 25 mL volumetric flask and make to volume with water. TMP 267 288.5 a AMP = adenosine 5′-monophosphate; CMP = cytidine 5′-monophosphate; GMP = guanosine 5′-monophosphate; IMP = inosine 5′-monophosphate; UMP = uridine 5′-monophosphate; TMP = thymidine 5′-monophosphate. (i) For starch-based products, transfer 2 × 4 mL prepared sample to two separate ultra centrifuge tubes and centrifuge at 3500 × g for 60 min, and then pool filtrates from both tubes. 
F. Sample Preparation
G. Extraction
Throughout the extraction procedure, do not let the cartridge run dry but drain to the top of the cartridge bed only. When draining the cartridge, the flow rate should be <2 mL/min. 
H. Chromatography
(a) Form gradients by low pressure mixing of the two mobile phases, A and B, with separation of nucleotides achieved using the procedure shown in Table 2011 .20C.
(b) Acquire spectral data between 210 and 300 nm using the photodiode array detector with chromatograms monitored at the specified wavelengths below for quantitation.
(1) IMP wavelength at 250 nm.
(2) AMP, GMP, and TMP wavelengths at 260 nm. where wtSS = weight of nucleotide in stock standard (mg), 50 = total volume of SS (mL), 10 3 = concentration conversion (mg/mL to μg/mL), PS% = percent purity, and 100 = mass conversion (% to decimal). where SS = concentration of nucleotide in stock standard (μg/mL), 2 = volume of nucleotide stock standard in working standard (mL), and 50 = total volume of working standard (mL).
(e) Concentration of TMP in calibration standards (CS):
where IS = concentration of nucleotide in IS (μg/mL), 1 = volume of IS in calibration standard (mL), and 25 = total volume of calibration standard (mL).
(f) Concentration of nucleotides in calibration standard (CS):
where WS = concentration of nucleotide in working standard (μg/mL), V WS = volume of working standard in CS (mL), and 25 = total volume of CS (mL).
(g) Determine the linear regression curve for the ratio of peak areas (nucleotide/TMP; y-axis) versus the ratio of concentrations (nucleotide/TMP; x-axis) for CSs and calculate the slope with the yintercept forced through 0.
(h) Interpolate the nucleotide contents in unknown samples from this calibration curve.
(1) For powders:
(2) For ready-to-feed liquids:
where A NT = nucleotide peak area in sample, A IS = TMP peak area in sample, L = linear regression slope of calibration curve, C IS = concentration of IS added to sample (μg/mL), V IS = volume of IS added to sample (mL), W S = weight of sample (g), 1000 = mass conversion of result (μg to mg),
Results and Discussion
The initial phase of method evaluation within the participating laboratories involved the analysis of a practice sample. The NIST 1849a SRM was selected for this purpose for a number of reasons: (1) as it was readily available in most laboratories, the method setup and evaluation could commence without receipt of shipped samples; (2) participants could evaluate method implementation in their laboratory against certified values; and (3) it provided additional confidence that there was no significant bias in method performance among all participants.
Precision and bias were evaluated for NIST 1849a practice samples as defined by the AOAC ERP (8).
All participating laboratories provided acceptable data for the practice sample (Table 1) (Tables 7-11 ). In some instances, statistical outliers were identified, but, where deemed to be reasonable to do so, these were retained in the data set for calculation of the method precision.
As the soy-based infant formula was not fortified with nucleotides and contained endogenous levels only, the precision for this sample was poor, as expected at concentrations near or below the HorRat value 0.7 0.6 0.6 n/a 0.6 CMP = cytidine 5′-monophosphate, UMP = uridine 5′-monophosphate, GMP = guanosine 5′-monophosphate, IMP = inosine 5′-monophosphate, AMP = adenosine 5′-monophosphate, 
